Project 2: Molecular Regulation of Kaiso in Prostate Cancer
项目2:Kaiso对前列腺癌的分子调控
基本信息
- 批准号:9211123
- 负责人:
- 金额:$ 12.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-30 至
- 项目状态:未结题
- 来源:
- 关键词:African AmericanAlabamaAndrogensApoptosisBindingCancer Death RatesCancer PatientCastrationCell Cycle ArrestCell NucleusCell ProliferationCellsCessation of lifeDNA MethylationDevelopmentDiagnosticDiseaseE-CadherinEpidermal Growth Factor ReceptorEpigenetic ProcessEvaluationGene DeletionGenesGeneticIndolentInstitutionInvestigationLinkMalignant Epithelial CellMalignant neoplasm of prostateMediatingMethylationMolecularMorehouse School of MedicineMusNeoplasm MetastasisNuclearPatientsPeptidesPhenotypePrimary NeoplasmProstate AdenocarcinomaProteinsReceptor SignalingRegulationRepressor ProteinsResistanceRoleSecondary toSignal TransductionTestingTherapeuticUniversitiesXenograft Modelautocrinebasecancer diagnosischromatin immunoprecipitationdesignepithelial to mesenchymal transitioninhibitor/antagonistmalenovelpre-clinicalpreventprognosticprostate cancer cell lineprotein protein interactiontumortumor growth
项目摘要
7. PROJECT SUMMARY/ABSTRACT
Although prostatic adenocarcinoma is the most commonly diagnosed cancer in U.S. males, the death rate
from this cancer is lower than would be expected. African Americans (AAs) who have prostate cancer (PCa)
typically have more aggressive disease and make up a disproportionate number of the deaths from this
disease; however, many patients with PCa will not die of PCa even if untreated (i.e., indolent prostate
cancer). We have recently studied the expression of the molecule, Kaiso, in PCa and found that Kaiso is
increased in aggressive PCa, especially in PCa in AAs. Also, we have found that Kaiso is involved in
facilitating the epigenetic suppression of genes (e.g., E-cadherin), and via this silencing of specific genes,
causing epithelial to mesenchymal transition (EMT) and androgen resistance of PCa. The objectives of our
proposal are to demonstrate that the nuclear expression of Kaiso is mediated through EGFR signaling and
that Kaiso can be targeted therapeutically to reduce EMT and associated metastases of PCa. To accomplish
this, we have outlined three specific aims.
7。项目摘要/摘要
尽管前列腺腺癌是美国男性最常见的癌症,但死亡率
从这个癌症中比预期的要低。患有前列腺癌(PCA)的非裔美国人(AAS)
通常患有更多的侵略性疾病,构成了这一死亡的数量不成比例
疾病;但是,即使未经治疗,许多患有PCA的患者也不会死于PCA(即,顽固的前列腺
癌症)。我们最近在PCA中研究了分子Kaiso的表达,发现Kaiso是
侵略性PCA增加,尤其是在AAS中的PCA中。另外,我们发现Kaiso参与了
促进基因的表观遗传抑制(例如E-钙粘蛋白),并通过对特定基因的沉默,
导致上皮上皮过渡(EMT)和PCA的雄激素耐药性。我们的目标
提案是要证明Kaiso的核表达是通过EGFR信号传导和
可以将Kaiso靶向治疗,以减少PCA的EMT和相关转移。完成
这,我们概述了三个具体目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Clayton Yates其他文献
Clayton Yates的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Clayton Yates', 18)}}的其他基金
Transcriptional Regulation of Breast Cancer Metastasis within the Tumor Microenvi
肿瘤微环境中乳腺癌转移的转录调控
- 批准号:
8774426 - 财政年份:2014
- 资助金额:
$ 12.94万 - 项目类别:
INFRASTRUCTURE CORE I: SHAREABLE INSTRUMENTATION FACILITY
基础设施核心 I:可共享仪器设施
- 批准号:
9360288 - 财政年份:2014
- 资助金额:
$ 12.94万 - 项目类别:
Transcriptional Regulation of Breast Cancer Metastasis within the Tumor Microenvi
肿瘤微环境中乳腺癌转移的转录调控
- 批准号:
8919859 - 财政年份:2014
- 资助金额:
$ 12.94万 - 项目类别:
MOLECULAR TARGETS FOR AA PROSTATE CANCER PATIENTS USING MIRNA PROFILING
使用 Mirna 分析确定 AA 前列腺癌患者的分子靶点
- 批准号:
8357143 - 财政年份:2011
- 资助金额:
$ 12.94万 - 项目类别:
1/2 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
1/2 莫尔豪斯医学院/塔斯基吉大学/阿拉巴马大学 Ca Ctr 合作伙伴关系
- 批准号:
10016078 - 财政年份:2005
- 资助金额:
$ 12.94万 - 项目类别:
相似海外基金
A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
氟班色林在接受雄激素抑制治疗前列腺癌的男性中的随机 II 期试验
- 批准号:
10195766 - 财政年份:2021
- 资助金额:
$ 12.94万 - 项目类别:
A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
氟班色林在接受雄激素抑制治疗前列腺癌的男性中的随机 II 期试验
- 批准号:
10407479 - 财政年份:2021
- 资助金额:
$ 12.94万 - 项目类别:
The Utility of Empiric Medical Treatment of Infertile Oligo-asthenospermic Men
经验性药物治疗对不育少弱精子症男性的效用
- 批准号:
8588703 - 财政年份:2007
- 资助金额:
$ 12.94万 - 项目类别:
A multiomic analysis of HER2/ERBB2 in African American men with prostate cancer
非洲裔美国前列腺癌男性 HER2/ERBB2 的多组学分析
- 批准号:
10800504 - 财政年份:1997
- 资助金额:
$ 12.94万 - 项目类别: